Zilico showcased at Digital Medicine and Medtech Event 2019

Wednesday 9th January 2019

Zilico CEO, Sameer Kothari, presented at the annual Digital Medicine and Medtech Showcase in San Francisco on January 9th, to announce how Zilico will be further developing a portfolio of cancer diagnostic devices based on our patented Electrical Impedance Spectroscopy (EIS) technology.

The JP Morgan Healthcare Conference event was an opportunity for commercial and investor networking and to share how Zilico have de-risked the business with the development of ZedScan, our cervical cancer diagnostic device, paving the way for a pipeline of products utilising  EIS technology.

Sameer discussed the company's future growth ambitions and whilst early days, the plans were well received.

Watch Proactive Investors interview with Sameer here